Steven J. Lynn is executive vice-president, pharmaceuticals for Regulatory Compliance Associates, Inc.
Verifying Compendial Methods
Experts Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, and Steven J. Lynn, executive vice-president, Pharmaceuticals for Regulatory Compliance Associates, discuss the verification of compendial methods.
GMPs for Emerging Therapies
Experts Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, and Steven J. Lynn, executive vice-president, Pharmaceuticals for Regulatory Compliance Associates, provide answers to frequently asked regulatory questions about advanced therapy medicinal products.
Conducting Effective Audits During and Post Pandemic
With appropriate planning and the proper use of technology, remote auditing can be as effective and informative as in-person auditing.